Improved virus purification processes for vaccines and gene therapy.
about
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic virusesManufacturing of AcMNPV baculovirus vectors to enable gene therapy trialsAqueous two-phase system (ATPS): an overview and advances in its applicationsRetroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display.Biomolecular engineering of virus-like particles aided by computational chemistry methods.Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus.Halophilic viruses with varying biochemical and biophysical properties are amenable to purification with asymmetrical flow field-flow fractionation.Application of aqueous two-phase micellar system to improve extraction of adenoviral particles from cell lysate.Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.Purification of influenza virus‐like particles using sulfated cellulose membrane adsorbers.Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination
P2860
Q26752807-4E53B0C7-A1F8-44FF-937E-820B77C20538Q26767368-FACB2A11-CA40-4751-A0B7-9094EB7C8265Q28078611-C5EC3039-1662-4E7B-A399-32C2EA3291F8Q36095367-455848D7-1C42-4764-A5C2-E4913AF5299CQ38588882-AE15F5AF-63EB-4FBB-A1C8-AE4B1220FE4CQ39952994-5E8AEBAF-BC76-4274-BB56-4BDDE987342EQ41919449-160C5E19-A750-45A2-909F-9BC4DA1294ECQ45875447-FF3EC2D9-6ED6-4370-A20C-A1EEBE211F29Q48505883-D7A48647-BEDB-42BC-B1F0-66A26340FDF2Q55533975-56DA05BA-5227-4339-B3B5-8D4B726C090AQ56355788-2B21D597-9275-4A41-946C-81313BE8DF40
P2860
Improved virus purification processes for vaccines and gene therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Improved virus purification processes for vaccines and gene therapy.
@en
type
label
Improved virus purification processes for vaccines and gene therapy.
@en
prefLabel
Improved virus purification processes for vaccines and gene therapy.
@en
P50
P356
P1476
Improved virus purification processes for vaccines and gene therapy.
@en
P2093
Piergiuseppe Nestola
P304
P356
10.1002/BIT.25545
P577
2015-03-10T00:00:00Z